Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 25, 2013 16:05 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentation at the 2013 Deutsche Bank BioFEST Conference

CAMBRIDGE, Mass., Nov. 25, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
November 06, 2013 16:05 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
November 05, 2013 08:00 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports Third Quarter 2013 Financial Results

CAMBRIDGE, Mass., Nov. 5, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
October 15, 2013 08:30 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of Third Quarter 2013 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., Oct. 15, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
September 04, 2013 09:00 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentations at Three Upcoming Investor Conferences

CAMBRIDGE, Mass., Sept. 4, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
August 06, 2013 16:05 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference

CAMBRIDGE, Mass., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
August 01, 2013 08:00 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports Second Quarter 2013 Financial Results

CAMBRIDGE, Mass., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs,...
July 26, 2013 13:18 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Potential for 2014 Market Entry of Generic Copaxone(R)

CAMBRIDGE, Mass., July 26, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today announced that the United States Court of Appeals for the Federal Circuit (the "Federal Circuit")...
July 16, 2013 09:00 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of Second Quarter 2013 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., July 16, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
June 25, 2013 08:30 ET | Source: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Issuance of U.S. Patent for Sialylation Technology

CAMBRIDGE, Mass., June 25, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...